anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

131,101-131,160 of 319,975

filter-aware
01
Slide 1
This is a short-seller research report cover/intro page.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller 1 hit
02
The slide uses the 'iceberg' metaphor to describe the hidden risks of the company's financial projections.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Villain Critique1 hit
03
This is a research note slide highlighting critical risks regarding customer concentration and declining game performance.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Villain Critique1 hit
04
This slide functions as a 'short-seller' research note, highlighting negative sentiment from former employees and questioning the validity of corporate PR.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Villain Critique1 hit
05
The slide uses investigative journalism techniques to undermine the CEO's credibility.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Villain Critique1 hit
06
The slide uses a bearish tone to argue against the company's growth projections.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
07
This is a short-seller research note exposing a contradiction between company projections and underlying developer performance data.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
08
The slide uses a 'company favorable' assumption model to demonstrate that even under best-case scenarios, the core business is declining.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
09
The slide uses a table to highlight specific growth projections and includes a testimonial quote to undermine the company's narrative.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
10
The slide uses a quote from a former employee and a direct excerpt from Google's policy to support its bearish thesis.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
11
Includes a Bloomberg terminal screenshot showing stock price movement and a snippet from an S-1 filing.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
12
Includes a screenshot of a Google Groups delivery failure notification.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
13
The slide uses a series of bullet points to document specific failed partnerships (Glu Mobile, Buck Hunter, Beeline Interactive, NFL) to undermine management credibility.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
14
Includes specific references to legal case 'Cooper v. Skillz, Inc.' and footnotes.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
15
Skillz, Inc. (SKLZ)Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Appendix Disclosure1 hit
16
Skillz, Inc. (SKLZ)Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Disclaimer1 hit
302
The slide uses direct quotes to undermine the value proposition of the OCS device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
303
This is a text-only slide serving as a section header or key point in a research note.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
304
The slide uses direct quotes from surgeons to build a bearish case against the company (TransMedics/Waleed).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
305
The slide uses a 'laundry list' format to present competitive threats, supported by product imagery.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
306
The slide uses a 'villain' narrative structure to frame TransMedics as vulnerable to upcoming competition.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
307
The slide uses expert testimony to build a bearish case against the incumbent (TransMedics).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
308
The slide uses expert testimony to undermine the value proposition of TransMedics' portability.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
309
The slide uses direct quotes from an OrganOx employee and a leading transplant surgeon to validate the thesis.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
310
The slide uses direct quotes from transplant surgeons and hepatologists to validate the thesis of market disruption.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
311
The slide highlights a competitive threat to TransMedics driven by OPO purchasing behavior.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
312
The slide uses direct quotes from an industry expert to build a bearish case against TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
313
The slide uses a direct quote to highlight a competitive threat to TransMedics' business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
314
The slide uses direct quotes from an organ procurement specialist to validate the thesis of market disruption.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
315
The slide uses direct quotes from a transplant surgeon to validate the thesis that TransMedics is at risk of being rendered obsolete by competitors.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
316
Includes verbatim transcripts from a transplant surgeon regarding competitive dynamics in the liver transplant market.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
317
TransMedics (TMDX)TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
318
The slide uses a combination of cost comparison and technical diagrams to argue for the obsolescence of the subject company's core product.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
319
The slide uses expert testimony to frame TransMedics as an overpriced incumbent being disrupted by a cheaper, established European technique (NRP).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
320
The slide uses direct quotes from a consultation call to highlight the competitive threat of NRP to TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
321
Includes citations from JAMA and American Journal of Transplantation.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
322
The slide contrasts the perceived limitations of TransMedics' technology with the functional advantages of NRP, supported by expert testimony and market evidence.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
323
The slide uses a 'canary in the coal mine' metaphor to frame the loss of a major customer as a leading indicator of broader market share erosion.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
324
The slide uses direct quotes from industry experts to validate the thesis of NRP market penetration.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
325
The slide uses a direct quote to frame the current market situation as overpriced and vulnerable to disruption, drawing an analogy to the Hepatitis C drug market.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
326
This slide functions as a 'villain critique' or 'fraud exposure' note, likely part of a short-seller research report.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
327
The slide uses direct quotes from former employees to build a case for corporate malfeasance and product failure.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
328
The slide uses a Q&A format to present testimony, highlighting specific instances of alleged misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
329
The slide uses a Q&A transcript format to substantiate claims about corporate governance and safety oversight failures.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
330
The slide uses direct quotes from former employees and industry peers to build a case against the reliability of the TransMedics OCS device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
331
Includes a direct quote from a CEO of a major OPO regarding a surgeon's resignation due to safety concerns.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
332
The slide presents a Q&A format to highlight a specific technical failure mode (necrosis) attributed to the device's design.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
333
The slide uses visual evidence (images of livers and CT scans) to support the argument that machine perfusion causes lasting tissue damage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
334
The slide uses a combination of narrative summary and direct Q&A excerpts to build a case against the company's product claims.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
335
The slide uses a Q&A format to highlight a specific failure in the procurement process.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
336
The slide presents a narrative of corporate deception regarding medical device performance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
337
The slide uses a Q&A format to highlight a perceived cover-up by the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
338
The slide uses a quote to highlight a perceived lack of transparency by the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
339
The slide presents a narrative of institutional failure and ethical concerns regarding medical device reporting.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
340
The slide uses a Q&A format to highlight a specific expert's negative experience with TransMedics equipment and corporate communication.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
341
The slide highlights a critical failure in safety protocols and regulatory compliance as perceived by an industry expert.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
342
The slide uses highlighted text to emphasize key allegations of non-reporting and unethical behavior.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
01
Slide 1
This is a classic 'short-and-distort' activist deck cover page, utilizing aggressive, inflammatory language to frame the thesis.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Introduction to Twist Bioscience's issues1 hit
02
Standard activist short report legal disclaimer.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Introduction to Twist Bioscience's issues1 hit
03
The slide uses strong, accusatory language typical of activist short-seller reports (e.g., 'Ponzi-like', 'fraudulent', 'Worldcom-esque').Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Introduction to Twist Bioscience's issues1 hit